Intermediate Reference Laboratory

What Intermediate Reference Laboratory does

The Intermediate Reference Laboratory (IRL) is a public-sector healthcare institution operated by the Government of Puducherry, India, established in 1963. It serves as the designated Intermediate Reference Laboratory for the Union Territory of Puducherry under India's central Revised National Tuberculosis Control Programme (RNTCP), and concurrently operates as the State TB Training and Demonstration Centre (STDC). Its core function is to provide specialized tuberculosis diagnostic services — including sputum smear microscopy, mycobacterial culture, and drug susceptibility testing — to patients referred from across the Union Territory, along with management of MDR-TB cases. Patient services are delivered free of charge as part of the public-health mandate.

The laboratory's technical infrastructure centers on a BSL-III containment facility equipped with BACTEC MGIT 960 systems for automated mycobacterial culture and DST. Beyond routine diagnostics, the IRL maintains an active research portfolio: it has filed an Indian patent (October 2011) related to the identification of new anti-TB drug candidates, and participates in international collaborations including a biomarkers study with Boston University/Boston Medical Centre and the New Jersey Medical School (UMDNJ), and a domestic biomarker research partnership with JIPMER funded at 15 crore rupees. Training programs delivered under the STDC banner target medical officers, laboratory technicians, and health workers at nominal fees of INR 8,000-12,000 per program.

The institution's revenue model is structurally non-commercial. It is funded by the Government of Puducherry through RNTCP allocations, with patient services provided free of charge and training fees set at cost-recovery levels well below operational expense. Consequently, there is no commercial go-to-market motion, no pricing strategy in the conventional sense, and no revenue diversification across customer segments. Its economic significance is best measured by public-health output (diagnoses performed, MDR-TB cases managed, trainees certified) rather than commercial revenue.

Name

Intermediate Reference Laboratory

Legal name

Government Hospital for Chest Diseases, Government of Puducherry

Website

https://ghcd.in

Company type

Private

Founded year

1963

Operating status

Operating

Headcount range

11–50 employees

Short description

The Government of Puducherry's designated Intermediate Reference Laboratory under RNTCP, providing specialized TB diagnostics, MDR-TB treatment, professional training, and biomarker research through public-sector funding.

Ownership category

akta.pro rank

Product category

Public Health Tuberculosis Diagnostics

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD)

akta.pro secondary industries

Reference & Esoteric Testing Laboratories (HLAFAMAJ), Local/County Public Health Laboratories (HLAJAIAC)

Keywords

• Tuberculosis diagnostics
• Chest disease treatment
• Public health laboratory
• RNTCP training
• MDR-TB testing

Headquarters

HQ city

Puducherry

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain

Pricing tiers

Distribution channels1 record

Marketing channels1 record

Core offering

The Intermediate Reference Laboratory (IRL) is a state-level tuberculosis diagnostic and training facility operated under the Government Hospital for Chest Diseases, Government of Puducherry, India. It provides specialized TB diagnostic services including sputum smear microscopy, mycobacterial culture, and drug susceptibility testing for MDR-TB detection, alongside RNTCP (Revised National Tuberculosis Control Program) training for healthcare workers, medical students, and laboratory technicians.

Product overview

Intermediate Reference Laboratory (IRL) is a government healthcare institution functioning as the designated Intermediate Reference Laboratory for the state of Puducherry under the Revised National Tuberculosis Control Programme (RNTCP). It operates as a unified healthcare platform offering TB diagnostic services including smear microscopy, culture, and drug sensitivity testing, MDR diagnosis laboratory facilities, DOTs Plus treatment site, and State TB Training and Demonstration Centre. The facility provides both RNTCP training for healthcare personnel and non-RNTCP short-term training programmes. It also conducts molecular biology research on TB pathogens including gene mutation analysis and PCR-based diagnostics. The institution serves as the State Reference Laboratory for quality assurance of TB testing across the state.

Differentiator

Problem solved

Functional benefit

Products and services

• TB Sputum Smear Microscopy
• MDR-TB Diagnosis and Drug Susceptibility Testing
• RNTCP Training Programs
• Designated Microscopy Centre (DMC) Quality Assurance

Quantifiable outcome

• 165 nursing personnel trained in RNTCP
• +3 more outcomes

Segments4 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Five partnerships are on record, tiered core and minor.

• JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research)coreStrategic or Co-development PartnerCollaborative research partner for biomarkers study for TB treatment failure and relapse. Departments of PSM, Microbiology, and Pulmonary Medicine at JIPMER work with IRL Puducherry on this 5-year project funded by 15 Crore rupees.
• Boston University and Boston Medical CentrecoreStrategic or Co-development PartnerInternational research collaborator on biomarkers study for TB risk and treatment outcomes. Part of multi-institutional study on TB treatment failure and relapse.
• New Jersey Medical School UMDNJcoreStrategic or Co-development PartnerInternational research collaborator on biomarkers study for TB risk and treatment outcomes. Part of multi-institutional study on TB treatment failure and relapse.
• Sri Venkateshwara Medical College and Research CentreminorStrategic or Co-development PartnerCollaborator on study of Genital Tuberculosis in women of reproductive age group. Project duration of 1 year with funding of 2 lakhs rupees.
• National Reference Laboratory (NRL)coreStrategic or Co-development PartnerMonitoring and accreditation partner for sputum microscopy, Line probe Assay, and mycobacterial culture and drug sensitivity testing on solid and liquid media for first and second line drugs.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• National Institute for Research in Tuberculosis (NIRT), Chennai: ICMR-affiliated TB research institute conducting clinical trials, epidemiology, and laboratory research on TB. Comparable as a government TB research and reference institution with similar molecular biology and drug-resistance research activities.
• National Institute of Tuberculosis and Respiratory Diseases (NITRD): Autonomous national TB and respiratory diseases institute in Delhi providing diagnostic, treatment, and training services. Directly comparable as a tertiary government TB institution performing culture, DST, and MDR-TB management alongside reference-laboratory functions.
• National JALMA Institute for Leprosy and Other Mycobacterial Diseases: ICMR institute in Agra focused on mycobacterial disease research and reference testing. Comparable as a government mycobacterial reference lab performing molecular characterization and drug-resistance studies.
• JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research): Tertiary medical institution in Puducherry collaborating with IRL on TB biomarkers research. Comparable as a research and diagnostics peer in TB microbiology and clinical investigations within the same geography.
• National Tuberculosis Institute (NTI): Central government TB training and reference laboratory in Bangalore that anchors India's RNTCP. Directly comparable to IRL Puducherry as a government-designated TB reference lab with training, QA, and DST functions under RNTCP.

Emerging players

• Christian Medical College (CMC) Vellore - Department of Microbiology: Private tertiary institution with an accredited mycobacteriology laboratory performing culture, DST, and molecular TB diagnostics. Comparable as a high-quality TB reference testing provider in southern India, though operating on a private healthcare model rather than government designation.
• P.D. Hinduja Hospital & Medical Research Centre - Microbiology Lab: Private reference laboratory in Mumbai with advanced molecular TB diagnostics capabilities including Line Probe Assay and BACTEC. Comparable as a private-sector TB reference lab offering culture, DST, and molecular drug-resistance testing.

Others

• Foundation for Innovative New Diagnostics (FIND): Global non-profit accelerating diagnostic access for TB and other diseases, partnering with national TB programs including India's RNTCP. Comparable as an ecosystem enabler that defines reference-lab standards and accredits TB testing workflows relevant to institutions like IRL Puducherry.
• World Health Organization - Global TB Programme: UN agency setting global TB diagnostic and treatment standards that inform India's RNTCP protocols. Comparable as a standards-setter whose guidelines directly govern IRL operations, accreditation, and methodology choices.

Broad incumbents

• Indian Council of Medical Research (ICMR): Apex government body funding and coordinating biomedical research in India, including TB reference laboratories and translational research programs. Comparable as the broader umbrella under which IRL Puducherry's research partnerships and accreditation linkages operate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/intermediate-reference-laboratory

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intermediate Reference Laboratory